Cargando…

Effect of rLH Supplementation during Controlled Ovarian Stimulation for IVF: Evidence from a Retrospective Analysis of 1470 Poor/Suboptimal/Normal Responders Receiving Either rFSH plus rLH or rFSH Alone

We retrospectively studied a real-life population of 1470 women undergoing IVF, with poor/suboptimal/normal ovarian responsiveness to controlled ovarian stimulation (COS), comparing the cumulative live birth rate (cLBR) when COS was performed using rFSH alone or rFSH + rLH in a 2:1 ratio. Overall, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canosa, Stefano, Carosso, Andrea Roberto, Mercaldo, Noemi, Ruffa, Alessandro, Evangelista, Francesca, Bongioanni, Francesca, Benedetto, Chiara, Revelli, Alberto, Gennarelli, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954443/ https://www.ncbi.nlm.nih.gov/pubmed/35329901 http://dx.doi.org/10.3390/jcm11061575

Ejemplares similares

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
por: Papaleo, Enrico, et al.
Publicado: (2014)

SAT-295 Low Dose rFSH Prior to HCG-rFSH Therapy in Kallmann Syndrome
por: Yoshizawa-Ogasawara, Atsuko, et al.
Publicado: (2019)

Comparison between cycles of the same patients when using recombinant luteinizing hormone + recombinant follicle stimulating hormone (rFSH), human menopausal gonadotropin + rFSH and rFSH only
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF
por: Spencer, Jessica B, et al.
Publicado: (2010)

Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF
por: Gomaa, Hala, et al.
Publicado: (2012)

Low dose of rFSH [100 IU] in controlled ovarian hyperstimulation response: a pilot study
por: Barbosa, Caio Parente, et al.
Publicado: (2014)

Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis
por: Bordewijk, E M, et al.
Publicado: (2019)

Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist
por: Chapon, Rita de Cassia Borges, et al.
Publicado: (2021)

Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI
por: Boudjenah, Radia, et al.
Publicado: (2012)

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016)

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
por: Leader, Arthur, et al.
Publicado: (2013)

A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System
por: Beresniak, Ariel, et al.
Publicado: (2023)

Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing
por: Bøtkjær, Jane Alrø, et al.
Publicado: (2022)

Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome
por: Prasad, Sudha, et al.
Publicado: (2013)

PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
por: Yovich, John L, et al.
Publicado: (2016)

Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal
por: GIZZO, SALVATORE, et al.
Publicado: (2015)

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

Letter to Editor on “Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome”
por: Morgante, Giuseppe
Publicado: (2014)

Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation
por: Drakakis, Peter, et al.
Publicado: (2009)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
por: Mennini, F. S., et al.
Publicado: (2018)

Comparing clomiphen citrate plus HMG with clomiphen citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: A prospective randomized study
por: Azargoon, Azam, et al.
Publicado: (2013)

The Role of Urinary LH and FSH in the Diagnosis of Pubertal Disorders
por: Tripathy, Manoranjan, et al.
Publicado: (2021)

Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population
por: Revelli, Alberto, et al.
Publicado: (2015)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART
por: Siristatidis, Charalampos, et al.
Publicado: (2021)

Oestrogen-selective modulation of FSH and LH secretion by pituitary gland
por: Mitwally, M F, et al.
Publicado: (2005)

Weak evidence of bright light effects on human LH and FSH
por: Kripke, Daniel F, et al.
Publicado: (2010)

Reduced FSH and LH action: implications for medically assisted reproduction
por: Bosch, E, et al.
Publicado: (2021)

Regulation of progesterone during follicular development by FSH and LH in sheep
por: Ding, Ziqiang, et al.
Publicado: (2022)

Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
por: Revelli, Alberto, et al.
Publicado: (2006)

Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: correlation with basal FSH and LH levels and LH/FSH ratio: a cross-sectional study
por: Racoubian, Eddie, et al.
Publicado: (2020)

FSH in vitro versus LH in vivo: similar genomic effects on the cumulus
por: Assidi, Mourad, et al.
Publicado: (2013)

Serum LH/FSH ratios in 87 infants with differences of sex development
por: Ljubicic, Marie Lindhardt, et al.
Publicado: (2023)

Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization
por: Bergandi, Loredana, et al.
Publicado: (2020)

Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition
por: Kawakita, Takako, et al.
Publicado: (2023)

Functional insight for β-glucuronidase in Escherichia coli and Staphylococcus sp. RLH1
por: Arul, Loganathan, et al.
Publicado: (2008)

Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
por: Olsson, Håkan, et al.
Publicado: (2015)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_poii42b4kju3lk0s13422gkk7o